JP2023514452A5 - - Google Patents
Info
- Publication number
- JP2023514452A5 JP2023514452A5 JP2022550908A JP2022550908A JP2023514452A5 JP 2023514452 A5 JP2023514452 A5 JP 2023514452A5 JP 2022550908 A JP2022550908 A JP 2022550908A JP 2022550908 A JP2022550908 A JP 2022550908A JP 2023514452 A5 JP2023514452 A5 JP 2023514452A5
- Authority
- JP
- Japan
- Prior art keywords
- binding
- cov
- scaffold
- sars
- spike protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981453P | 2020-02-25 | 2020-02-25 | |
| US62/981,453 | 2020-02-25 | ||
| US202063002249P | 2020-03-30 | 2020-03-30 | |
| US63/002,249 | 2020-03-30 | ||
| US202062706225P | 2020-08-05 | 2020-08-05 | |
| US62/706,225 | 2020-08-05 | ||
| US202063091291P | 2020-10-13 | 2020-10-13 | |
| US63/091,291 | 2020-10-13 | ||
| PCT/US2021/019739 WO2021173879A1 (en) | 2020-02-25 | 2021-02-25 | Identification of biomimetic viral peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023514452A JP2023514452A (ja) | 2023-04-05 |
| JP2023514452A5 true JP2023514452A5 (cg-RX-API-DMAC7.html) | 2024-03-05 |
Family
ID=77492020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550908A Withdrawn JP2023514452A (ja) | 2020-02-25 | 2021-02-25 | 生体模倣ウイルスペプチドの特定及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230242592A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4110366A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023514452A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220158723A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115461068A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021227918A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3172878A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL295863A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021173879A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20220552A (es) | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| JP7854660B2 (ja) | 2020-05-22 | 2026-05-07 | 国立研究開発法人理化学研究所 | コロナウイルスに対する多重抗原ペプチドおよびこれを含む免疫賦活化組成物 |
| MX2022014598A (es) | 2020-05-26 | 2023-03-31 | Regeneron Pharma | Anticuerpos anti-glicoproteína espicular sars-cov-2 y fragmentos de unión al antígeno. |
| CR20220660A (es) | 2020-06-03 | 2023-02-17 | Regeneron Pharma | Métodos para tratar o prevenir infecciones por sars-cov2 y covid-19 con anticuerpos de glicoproteína espícular anti-sars-cov-2 |
| EP4370210A1 (en) | 2021-07-14 | 2024-05-22 | Regeneron Pharmaceuticals, Inc. | Anti-sars-cov-2-spike glycoprotein antibodies and antigen-binding fragments |
| EP4396204A4 (en) | 2021-09-17 | 2025-11-12 | David Kotlyar | Oral vaccine via dental bacteria and peptides released to prevent COVID-19 infection |
| IT202200025416A1 (it) * | 2022-12-13 | 2024-06-13 | Univ Pisa | Biosensore per la rilevazione di particelle virali |
| CN117153245B (zh) * | 2023-10-18 | 2024-03-19 | 无锡市疾病预防控制中心 | 预测新型冠状病毒S蛋白RBD区域与hACE2受体相互作用的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101080237A (zh) * | 2003-04-28 | 2007-11-28 | 塞阔伊亚药品公司 | 用于治疗、控制和预防冠状病毒感染的抗病毒剂 |
| CN1884303A (zh) * | 2005-06-20 | 2006-12-27 | 中国医学科学院基础医学研究所 | SARS-CoV病毒结构蛋白的融合蛋白及其高量表达与纯化和用途 |
| WO2017046801A1 (en) * | 2015-09-17 | 2017-03-23 | Ramot At Tel-Aviv University Ltd. | Coronaviruses epitope-based vaccines |
| RU2019121801A (ru) * | 2016-12-14 | 2021-01-15 | Лигандал, Инк. | Композиции и способы для доставки полезной нагрузки в виде нуклеиновой кислоты и/или белка |
| US11365239B2 (en) * | 2020-03-20 | 2022-06-21 | Tsb Therapeutics (Beijing) Co., Ltd. | Anti-SARS-COV-2 antibodies and uses thereof |
-
2021
- 2021-02-25 KR KR1020227033145A patent/KR20220158723A/ko active Pending
- 2021-02-25 WO PCT/US2021/019739 patent/WO2021173879A1/en not_active Ceased
- 2021-02-25 IL IL295863A patent/IL295863A/en unknown
- 2021-02-25 JP JP2022550908A patent/JP2023514452A/ja not_active Withdrawn
- 2021-02-25 AU AU2021227918A patent/AU2021227918A1/en active Pending
- 2021-02-25 CA CA3172878A patent/CA3172878A1/en active Pending
- 2021-02-25 CN CN202180031498.6A patent/CN115461068A/zh active Pending
- 2021-02-25 EP EP21760562.5A patent/EP4110366A4/en active Pending
-
2022
- 2022-08-24 US US17/822,099 patent/US20230242592A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2742739T3 (es) | Proteínas de fusión para uso como mejoradores inmunogénicos para inducir respuestas de células T específicas de antígenos | |
| ES2258796T3 (es) | Proteinas de fusion que contienen proteinas de estres para inducir respuestas inmunitarias. | |
| JP2022533318A5 (cg-RX-API-DMAC7.html) | ||
| US9943583B2 (en) | Proline-rich peptides protective against S. pneumoniae | |
| JP2024522385A5 (cg-RX-API-DMAC7.html) | ||
| JP2020169191A5 (cg-RX-API-DMAC7.html) | ||
| AU2013250711A1 (en) | Long-acting oxyntomodulin variants and methods of producing same | |
| JP2008535800A5 (cg-RX-API-DMAC7.html) | ||
| JP2008504012A5 (cg-RX-API-DMAC7.html) | ||
| JP2011518179A5 (cg-RX-API-DMAC7.html) | ||
| JP2015536134A5 (cg-RX-API-DMAC7.html) | ||
| CN113453703A (zh) | 包括胰岛素和对胰高血糖素和glp-1和gip受体均具有活性的三重激动剂的药物组合物 | |
| CN113260377B (zh) | 脂肽构建块和合成病毒样颗粒 | |
| CN111655284A (zh) | 流感病毒疫苗及其用途 | |
| CN105229025A (zh) | 位点特异性胰岛素缀合物 | |
| CN113769080B (zh) | 多肽免疫偶联物及其应用 | |
| JP4199421B2 (ja) | デキストラン−レプチン結合体、医薬組成物および関連方法 | |
| WO2008154867A1 (fr) | Composé immunogénique | |
| JP2012521207A5 (cg-RX-API-DMAC7.html) | ||
| KR20200136774A (ko) | Rsv의 f 단백질-항체 복합체 및 이를 포함하는 조성물 | |
| JP2025519475A5 (cg-RX-API-DMAC7.html) | ||
| EP1001978B1 (en) | Angiotensin derivatives | |
| BR112019026336A2 (pt) | forma de sal de cloridrato de um peptídeo análogo da porção c-terminal de c5a e o uso da mesma, composição, método para induzir uma resposta imune contra uma infecção ou câncer, kit e composto para aumentar uma resposta imune para um agente imunogênico | |
| JP2023534987A5 (cg-RX-API-DMAC7.html) | ||
| RU2014117975A (ru) | Гибридные белки и белковые конъюгаты на основе белков теплового шока-70 (бтш70) и способы их применения (варианты) |